Sascha Gerdes

5.4k total citations
116 papers, 2.5k citations indexed

About

Sascha Gerdes is a scholar working on Immunology, Dermatology and Physiology. According to data from OpenAlex, Sascha Gerdes has authored 116 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 97 papers in Immunology, 74 papers in Dermatology and 20 papers in Physiology. Recurrent topics in Sascha Gerdes's work include Psoriasis: Treatment and Pathogenesis (84 papers), Dermatology and Skin Diseases (71 papers) and Asthma and respiratory diseases (20 papers). Sascha Gerdes is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (84 papers), Dermatology and Skin Diseases (71 papers) and Asthma and respiratory diseases (20 papers). Sascha Gerdes collaborates with scholars based in Germany, United States and Switzerland. Sascha Gerdes's co-authors include Ulrich Mrowietz, Martin Rostami‐Yazdi, Michael Weichenthal, Andreas Pinter, Dagmar Wilsmann‐Theis, Rui Han, C. Papavassilis, Rotraut Mößner, Diamant Thaçi and Sandra Philipp and has published in prestigious journals such as New England Journal of Medicine, Nature Genetics and International Journal of Molecular Sciences.

In The Last Decade

Sascha Gerdes

108 papers receiving 2.4k citations

Peers

Countries citing papers authored by Sascha Gerdes

Since Specialization

Citations

This map shows the geographic impact of Sascha Gerdes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sascha Gerdes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sascha Gerdes more than expected).

Fields of papers citing papers by Sascha Gerdes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sascha Gerdes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sascha Gerdes. The network helps show where Sascha Gerdes may publish in the future.

Co-authorship network of co-authors of Sascha Gerdes

This figure shows the co-authorship network connecting the top 25 collaborators of Sascha Gerdes. A scholar is included among the top collaborators of Sascha Gerdes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sascha Gerdes. Sascha Gerdes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Long‐Term Impact of Guselkumab on Skin, Sexuality, and Perceived Stigmatization in Patients With Psoriasis in Routine Clinical Practice: Week 76 Effectiveness and Safety Results From the Prospective German Multicenter G‐ EPOSS Study 2025 ·The Journal of Dermatology ·Sascha Gerdes, Peter Weisenseel, (unknown), (unknown), Sebastian Zimmer, Alexander Otto, Friedemann Taut, (unknown), (unknown), (unknown), (unknown), (unknown)	0
2	History, clinical presentation, therapy, and patient reported outcomes of mucosal lichen planus: a cross‐sectional study 2025 ·JDDG Journal der Deutschen Dermatologischen Gesellschaft ·(unknown), (unknown), (unknown), Sabine Sennhenn‐Kirchner, Sascha Gerdes, Wiebke Sondermann, (unknown), Matthias Goebeler, Dagmar Wilsmann‐Theis, Claudia Günther, Christian Kromer, Rotraut Mößner	0
3	Anamnese, klinische Merkmale, Therapie und patientenberichtete Ergebnisse bei Lichen ruber mucosae: Eine Querschnittsstudie 2025 ·JDDG Journal der Deutschen Dermatologischen Gesellschaft ·(unknown), (unknown), (unknown), Sabine Sennhenn‐Kirchner, Sascha Gerdes, Wiebke Sondermann, (unknown), Matthias Goebeler, Dagmar Wilsmann‐Theis, Claudia Günther, Christian Kromer, Rotraut Mößner	1
4	Tolerability of Narrow-band Ultraviolet-B Phototherapy for Different Dermatological Diseases in Relation to Co-medications 2024 ·Acta Dermato Venereologica ·(unknown), Ann‐Sophie Bohne, Sascha Gerdes, Stephan Weidinger, Michael Weichenthal	1
5	Tralokinumab Treatment of Atopic Dermatitis Induces a Progressive Transcriptomic Response 2024 ·Journal of Investigative Dermatology ·(unknown), Inken Harder, Dora Stölzl, Matthias Hübenthal, (unknown), J. Hartmann, (unknown), (unknown), Sascha Gerdes, Stephan Weidinger	2
6	Inhibition of RNase 7 by RNase inhibitor promotes inflammation and Staphylococcus aureus growth: Implications for atopic dermatitis 2024 ·Allergy ·Franziska Rademacher, (unknown), Regine Gläser, Lena Schröder, (unknown), Joachim Bartels, Sascha Gerdes, Dora Stölzl, Elke Rodríguez, Katinka Döhner, Stephan Weidinger, Thomas Werfel, Jürgen Harder	5
7	Izokibep for the treatment of moderate-to-severe plaque psoriasis: a phase II, randomized, placebo-controlled, double-blind, dose-finding multicentre study including long-term treatment 2023 ·British Journal of Dermatology ·Sascha Gerdes, Petra Staubach, Thomas Dirschka, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Joachim Feldwisch, (unknown), S. Ohlman, Paul M. Peloso, Nikolai C. Brun, Fredrik Y. Frejd	16
8	Effectiveness, safety and quality‐of‐life effects of guselkumab and ustekinumab in patients with psoriasis: Week 104 results from the non‐interventional, prospective, German multicentre PERSIST study 2023 ·Journal of the European Academy of Dermatology and Venereology ·Sascha Gerdes, Matthias Hoffmann, K. Asadullah, Bernhard Korge, (unknown), Nadine Krüger, (unknown), (unknown), (unknown), Sven Wegner, (unknown), Friedemann Taut, Michael Sticherling	8
9	Guselkumab demonstrates long-term efficacy and maintenance of treatment response postwithdrawal in systemic treatment-naïve patients and nonresponders to fumaric acid esters: results from parts II and III of a randomized active-comparator-controlled phase IIIb trial (POLARIS) 2023 ·British Journal of Dermatology ·Diamant Thaçi, Andreas Pinter, Michael Sebastian, Christian Termeer, Michael Sticherling, Sascha Gerdes, Knut Schäkel, Sven Wegner, (unknown), Holger Bartz, Christian Rausch, Friedemann Taut, Kilian Eyerich	1
10	Effects of psoriasis and psoralen exposure on the somatic mutation landscape of the skin 2023 ·Nature Genetics ·Sigurgeir Ólafsson, Elke Rodríguez, Andrew Lawson, Federico Abascal, Axel Rosendahl Huber, (unknown), Philip H. Jones, Sascha Gerdes, Iñigo Martincorena, Stephan Weidinger, Peter J. Campbell, Carl A. Anderson	4
11	Effects of Early Emollient Use in Children at High Risk of Atopic Dermatitis: A German Pilot Study 2023 ·Acta Dermato Venereologica ·Inken Harder, Dora Stölzl, (unknown), (unknown), Elke Rodríguez, (unknown), Sebastian Kerzel, Michael Kabesch, Denise Küster, Jochen Schmitt, Regina Fölster‐Holst, Sascha Gerdes, Hila Emmert, Stephan Weidinger	7
12	Patient-reported well-being in value-based care using tildrakizumab in a real-world setting: protocol of a multinational, phase IV, 1-cohort prospective observational study (the POSITIVE study) 2023 ·BMJ Open ·Matthias Augustin, Rachel Sommer, E. Daudén, Philip Laws, E.M.G.J. de Jong, Gabriella Fabbrocini, Luigi Naldi, Alexander A. Navarini, Jo Lambert, Z. Reguiaï, Sascha Gerdes, (unknown), Teresa Obis, Ismail Kasujee, Ulrich Mrowietz	8
13	Depression, a major comorbidity of psoriatic disease, is caused by metabolic inflammation 2023 ·Journal of the European Academy of Dermatology and Venereology ·Ulrich Mrowietz, Melike Sümbül, Sascha Gerdes	37
14	Real‐world evidence from the non‐interventional, prospective, German multicentre PERSIST study of patients with psoriasis after 1 year of treatment with guselkumab 2022 ·Journal of the European Academy of Dermatology and Venereology ·Sascha Gerdes, K. Asadullah, Matthias Hoffmann, Bernhard Korge, (unknown), Sven Wegner, (unknown), (unknown), Michael Sticherling	16
15	Blood transcriptome profiling identifies 2 candidate endotypes of atopic dermatitis 2022 ·Journal of Allergy and Clinical Immunology ·Lena Möbus, Elke Rodríguez, Inken Harder, (unknown), Silke Szymczak, Matthias Hübenthal, Dora Stölzl, Sascha Gerdes, Andreas Kleinheinz, Susanne Abraham, Annice Heratizadeh, Christiane Handrick, Eva Haufe, Thomas Werfel, Jochen Schmitt, Stephan Weidinger	33
16	Tildrakizumab efficacy and safety in patients with psoriasis and concomitant metabolic syndrome: post hoc analysis of 5‐year data from reSURFACE 1 and reSURFACE 2 2022 ·Journal of the European Academy of Dermatology and Venereology ·Anthony P. Fernandez, E. Daudén, Sascha Gerdes, Mark Lebwohl, Alan Menter, C. Leonardi, Melinda Gooderham, Kurt Gebauer, Yayoi Tada, J.‐P. Lacour, Luca Bianchi, Alexander Egeberg, Ignasi Pau‐Charles, Alan M. Mendelsohn, Stephen J. Rozzo, Nehal N. Mehta	15
17	Humoral protection to SARS-CoV2 declines faster in patients on TNF alpha blocking therapies 2021 ·RMD Open ·Ulf Geisen, Melike Sümbül, Florian Tran, (unknown), (unknown), (unknown), (unknown), Ann Carolin Longardt, Paula Hoff, Peter J. Morrison, (unknown), Rainald Zeuner, Jan Henrik Schirmer, Andrea Steinbach, Susanna Nikolaus, Sascha Gerdes, Stefan Schreiber, Petra Bächer, Bimba F. Hoyer	12
18	Atopic dermatitis displays stable and dynamic skin transcriptome signatures 2020 ·Journal of Allergy and Clinical Immunology ·Lena Möbus, Elke Rodríguez, Inken Harder, Dora Stölzl, (unknown), Sascha Gerdes, Andreas Kleinheinz, Susanne Abraham, Annice Heratizadeh, Christiane Handrick, Eva Haufe, Thomas Werfel, Jochen Schmitt, Stephan Weidinger	85
19	Elevated NK-cell transcriptional signature and dysbalance of resting and activated NK cells in atopic dermatitis 2020 ·Journal of Allergy and Clinical Immunology ·Lena Möbus, Elke Rodríguez, Inken Harder, Agatha Schwarz, Ulrike Wehkamp, Dora Stölzl, (unknown), Sascha Gerdes, Thomas Litman, Andreas Kleinheinz, Susanne Abraham, Annice Heratizadeh, Christiane Handrick, Eva Haufe, Jochen Schmitt, Thomas Werfel, Stephan Weidinger	21
20	Drug survival and reasons for drug discontinuation in palmoplantar pustulosis: a retrospective multicenter study 2019 ·JDDG Journal der Deutschen Dermatologischen Gesellschaft ·Christian Kromer, Dagmar Wilsmann‐Theis, Sascha Gerdes, Sandra Philipp, Marthe‐Lisa Schaarschmidt, Astrid Schmieder, Mohammed Dakna, (unknown), Wiebke K. Peitsch, Rotraut Mößner	23

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact